BACKGROUND AND PURPOSE: Evidence to guide patient selection for IA therapy in acute basilar artery thrombosis is lacking. The GCS is frequently used as a selection criterion, based on the view that higher GCS correlates with better neurologic outcome. This view has not been systematically studied. We hypothesize that low GCS does not correlate with poor outcome and that it should not preclude IA therapy. MATERIALS AND METHODS: We included 40 consecutive patients with basilar artery thrombosis treated with IA therapy. Clinical characteristics, GCS, time to intervention, and postprocedural TIMI scores were collected. Recanalization was defined as TIMI grade 2 or 3; clinical outcome was measured by 90-day mRS. RESULTS: Median patient age was 63.5 years. Most presented with gaze palsies (67.5%) or hemiparesis (45%). Median GCS was 9, the median time to intervention was 7.2 hours, and recanalization rate was 82.5%. Good neurologic outcome (mRS ≤ 1) occurred in 30%. There was no correlation between GCS and 90-day mRS (Spearman ρ - 0.174, P = .283). Equal numbers of patients with good neurologic outcome of mRS ≤ 1 (n = 12) had a GCS of ≤6 or >6. In those with GCS ≤ 6 for >3 hours, 33.3% had good neurologic outcome-a similar rate to that of the overall cohort. Statistical significance was demonstrated between time to IA therapy within 6 hours and mRS ≤ 2. CONCLUSIONS: Low GCS score did not correlate with poor neurologic outcome in patients with acute basilar artery thrombosis managed with IA therapy. It is not appropriate to exclude patients from IA therapy on the basis of low GCS.
BACKGROUND AND PURPOSE: Evidence to guide patient selection for IA therapy in acute basilar artery thrombosis is lacking. The GCS is frequently used as a selection criterion, based on the view that higher GCS correlates with better neurologic outcome. This view has not been systematically studied. We hypothesize that low GCS does not correlate with poor outcome and that it should not preclude IA therapy. MATERIALS AND METHODS: We included 40 consecutive patients with basilar artery thrombosis treated with IA therapy. Clinical characteristics, GCS, time to intervention, and postprocedural TIMI scores were collected. Recanalization was defined as TIMI grade 2 or 3; clinical outcome was measured by 90-day mRS. RESULTS: Median patient age was 63.5 years. Most presented with gaze palsies (67.5%) or hemiparesis (45%). Median GCS was 9, the median time to intervention was 7.2 hours, and recanalization rate was 82.5%. Good neurologic outcome (mRS ≤ 1) occurred in 30%. There was no correlation between GCS and 90-day mRS (Spearman ρ - 0.174, P = .283). Equal numbers of patients with good neurologic outcome of mRS ≤ 1 (n = 12) had a GCS of ≤6 or >6. In those with GCS ≤ 6 for >3 hours, 33.3% had good neurologic outcome-a similar rate to that of the overall cohort. Statistical significance was demonstrated between time to IA therapy within 6 hours and mRS ≤ 2. CONCLUSIONS: Low GCS score did not correlate with poor neurologic outcome in patients with acute basilar artery thrombosis managed with IA therapy. It is not appropriate to exclude patients from IA therapy on the basis of low GCS.
Authors: G Schulte-Altedorneburg; G F Hamann; M Mull; D Kühne; M Liebetrau; W Weber; H Brückmann; T E Mayer Journal: AJNR Am J Neuroradiol Date: 2006 Nov-Dec Impact factor: 3.825
Authors: M R Macleod; S M Davis; P J Mitchell; R P Gerraty; G Fitt; G J Hankey; E G Stewart-Wynne; D Rosen; J J McNeil; C F Bladin; B R Chambers; G K Herkes; D Young; G A Donnan Journal: Cerebrovasc Dis Date: 2005-05-30 Impact factor: 2.762
Authors: G Schulte-Altedorneburg; H Brückmann; G F Hamann; M Mull; M Liebetrau; W Weber; D Kühne; T E Mayer Journal: AJNR Am J Neuroradiol Date: 2007-02 Impact factor: 3.825
Authors: Simon Nagel; Peter D Schellinger; Marius Hartmann; Eric Juettler; Hagen B Huttner; Peter Ringleb; Stefan Schwab; Martin Köhrmann Journal: Stroke Date: 2008-10-16 Impact factor: 7.914
Authors: M Arnold; K Nedeltchev; G Schroth; R W Baumgartner; L Remonda; T J Loher; F Stepper; M Sturzenegger; B Schuknecht; H P Mattle Journal: J Neurol Neurosurg Psychiatry Date: 2004-06 Impact factor: 10.154
Authors: P Mordasini; C Brekenfeld; J V Byrne; U Fischer; M Arnold; M R Heldner; R Lüdi; H P Mattle; G Schroth; J Gralla Journal: AJNR Am J Neuroradiol Date: 2012-06-21 Impact factor: 3.825
Authors: Y-I Eom; Y-H Hwang; J M Hong; J W Choi; Y C Lim; D-H Kang; Y-W Kim; Y-S Kim; S Y Kim; J S Lee Journal: AJNR Am J Neuroradiol Date: 2014-07-17 Impact factor: 3.825